Related references
Note: Only part of the references are listed.Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency
Andrew A. M. Morris et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
Enzyme replacement prevents neonatal death, liver damage, and osteoporosis in murine homocystinuria
Tomas Majtan et al.
FASEB JOURNAL (2017)
Cystathionine β-synthase deficiency: Of mice and men
Warren D. Kruger
MOLECULAR GENETICS AND METABOLISM (2017)
Engineering and Characterization of an Enzyme Replacement Therapy for Classical Homocystinuria
Tomas Majtan et al.
BIOMACROMOLECULES (2017)
Enzyme replacement with PEGylated cystathionine β-synthase ameliorates homocystinuria in murine model
Erez M. Bublil et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Interruption of enzyme replacement therapy in Gaucher disease
J. Goldblatt et al.
SAMJ SOUTH AFRICAN MEDICAL JOURNAL (2016)
Hydrogen Sulfide Promotes Tet1-and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis
Ruili Yang et al.
IMMUNITY (2015)
Liver transplantation for a patient with homocystinuria
Niang-Cheng Lin et al.
PEDIATRIC TRANSPLANTATION (2012)
Cystathionine beta-synthase null homocystinuric mice fail to exhibit altered hemostasis or lowering of plasma homocysteine in response to betaine treatment
Kenneth N. Maclean et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Liver failure and neurologic disease in a patient with homocystinuria
SE Snyderman
MOLECULAR GENETICS AND METABOLISM (2006)
Effect of discontinuing of laronidase in a patient with mucopolysaccharidosis type I
AT Anbu et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
Vascular outcome in patients with homocystinuria due to cystathionine β-synthase deficiency treated chronically -: A multicenter observational study
S Yap et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Share Paper
